Table 5_2_3.1
Adult patients with HIV and CD4 count ≤ 50 who received Mycobacterium avium complex (MAC) prophylaxis,a United States, 2004 and 2006
| |
|
2006 |
2004 |
| Population group |
Percent |
SE |
Percent |
SE |
| Total |
|
88.2 |
1.3 |
82.2 |
1.4 |
| Age |
18–44 |
88.0 |
1.6 |
84.3 |
1.6 |
| 45 and over |
88.6 |
2.4 |
77.0 |
3.0 |
| Race |
Non-Hispanic, White |
82.8 |
3.8 |
83.0 |
3.1 |
| Non-Hispanic, Black |
88.5 |
1.6 |
80.8 |
1.9 |
| Hispanic |
91.5 |
2.7 |
85.6 |
3.1 |
| Other |
DSU |
DSU |
DSU |
DSU |
| Gender |
Male |
87.7 |
1.6 |
82.9 |
1.6 |
| Female |
89.8 |
2.5 |
80.2 |
3.1 |
| Health insurance |
Private |
91.3 |
4.2 |
80.0 |
6.4 |
| Medicaid |
87.1 |
2.1 |
80.3 |
2.3 |
| Medicare/dual eligible |
85.2 |
3.0 |
79.8 |
3.2 |
| Ryan White/uninsured |
91.8 |
2.2 |
86.6 |
2.3 |
a For HIV patients having at least two CD4 tests ≤ 50 during the year.
DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: SE: standard error.
Source: Agency for Healthcare Research and Quality, Center for Delivery, Organization, and Markets, HIV Research Network.